Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence for a new physiological role of hepatic NADPH:ferricytochrome (P-450) oxidoreductase. Direct electron input to the microsomal fatty acid chain elongation system.

× No keyword cloud information.

25 in total

1. Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution.

Authors: Q Zhao; S Modi; G Smith; M Paine; P D McDonagh; C R Wolf; D Tew; L Y Lian; G C Roberts; H P Driessen
Journal: Protein Sci Date: 1999-02 Impact factor: 6.725

2. Consequences of POR mutations and polymorphisms.

Authors: Walter L Miller; Vishal Agrawal; Duanpen Sandee; Meng Kian Tee; Ningwu Huang; Ji Ha Choi; Kari Morrissey; Kathleen M Giacomini
Journal: Mol Cell Endocrinol Date: 2010-11-09 Impact factor: 4.102

3. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.

Authors: Yi Jin; Mo Chen; Trevor M Penning; Walter L Miller
Journal: Biochem J Date: 2015-05-15 Impact factor: 3.857

4. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.

Authors: Xiu Jun Wang; Mark Chamberlain; Olga Vassieva; Colin J Henderson; C Roland Wolf
Journal: Biochem J Date: 2005-06-15 Impact factor: 3.857

5. Cloning, functional expression, and subcellular localization of multiple NADPH-cytochrome P450 reductases from hybrid poplar.

Authors: Dae-Kyun Ro; Jürgen Ehlting; Carl J Douglas
Journal: Plant Physiol Date: 2002-12 Impact factor: 8.340

6. Regulation of gap junction function and Connexin 43 expression by cytochrome P450 oxidoreductase (CYPOR).

Authors: Srikanth R Polusani; Rekha Kar; Manuel A Riquelme; Bettie Sue Masters; Satya P Panda
Journal: Biochem Biophys Res Commun Date: 2011-06-25 Impact factor: 3.575

7. Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.

Authors: Karen M McCammon; Satya P Panda; Chuanwu Xia; Jung-Ja P Kim; Daniela Moutinho; Michel Kranendonk; Richard J Auchus; Eileen M Lafer; Debashis Ghosh; Pavel Martasek; Rekha Kar; Bettie Sue Masters; Linda J Roman
Journal: J Biol Chem Date: 2016-08-05 Impact factor: 5.157

8. NADPH:cytochrome P-450(c) reductase: biochemical characterization in rat brain and cultured neurons and evolution of activity during development.

Authors: J F Ghersi-Egea; A Minn; J L Daval; Z Jayyosi; V Arnould; H Souhaili-El Amri; G Siest
Journal: Neurochem Res Date: 1989-09 Impact factor: 3.996

9. Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.

Authors: Taninee Sahakitrungruang; Ningwu Huang; Meng Kian Tee; Vishal Agrawal; William E Russell; Patricia Crock; Nuala Murphy; Claude J Migeon; Walter L Miller
Journal: J Clin Endocrinol Metab Date: 2009-10-16 Impact factor: 5.958

10. Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle x-ray scattering.

Authors: Jacqueline Ellis; Aldo Gutierrez; Igor L Barsukov; Wei-Cheng Huang; J Günter Grossmann; Gordon C K Roberts
Journal: J Biol Chem Date: 2009-10-26 Impact factor: 5.157